Transmission of drug-resistant HIV after an occupational exposure despite postexposure prophylaxis with a combination drug regimen.
about
Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxisAntiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxisOccupationally acquired human immunodeficiency virus (HIV) infection: national case surveillance data during 20 years of the HIV epidemic in the United States.Prevention of human immunodeficiency virus and AIDS: postexposure prophylaxis (including health care workers)Occupational exposure to HIV and the use of post-exposure prophylaxis.Subsequent HIV infection among men who have sex with men who used non-occupational post-exposure prophylaxis at a Boston community health center: 1997-2013Local phylogenetic analysis identifies distinct trends in transmitted HIV drug resistance: implications for public health interventions.Post-exposure prophylaxis for HIV infection.Best practice for needlestick injuries.Timing, adherence, resistance, and ... persistence? new insight into the mechanisms of failure of HIV type 1 postexposure prophylaxis.Antiretroviral drug resistance among patients with human immunodeficiency virus who act as sources or potential sources in occupational accidents involving healthcare workers.Antiretroviral drug resistance in human immunodeficiency virus-infected source patients for occupational exposures to healthcare workers.Building better programs to prevent transmission of blood-borne pathogens to healthcare personnel: progress in the workplace, but still no end in sight.[HIV prophylaxis kits. A concept for emergency treatment in the context of postexposure prophylaxis].Expert consensus statement on the science of HIV in the context of criminal law
P2860
Q22242951-F82DBB79-8B77-4E59-AA96-8AA8C0313B4DQ28085433-D8A76EE4-9179-4462-89C7-951DEBB28DD4Q30771786-652D6825-F27D-434C-B7C7-303EF52AB27AQ34619859-2C483D78-4845-4456-A9C4-017EC88895CFQ34656428-262B78BF-CF92-4D5A-9C40-10ECCB821E38Q34802731-1042660F-35DA-4268-9E0B-80E0DE424B1FQ35028707-68153A98-9196-4A38-B439-EF45A624BA1EQ37866814-07A978B3-3611-4C4C-A3EC-683BB4E882B9Q42221692-03463EA0-57F6-458E-904A-A23DB6530209Q42938571-1747221D-4F94-445A-91C2-93FCC4E45B38Q45423472-EB005373-9FF2-4B8C-A491-E94117175AC1Q45710570-EE8F93BD-9374-43B6-8C01-E81A108606A0Q51804765-8D5C45B1-1133-4E80-BFF5-FE054915C1B5Q53808497-412ACF07-5393-426B-944A-2AF8C8206E95Q56911620-06F9D4B5-27C8-4796-8FA1-6C8B14F69A53
P2860
Transmission of drug-resistant HIV after an occupational exposure despite postexposure prophylaxis with a combination drug regimen.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Transmission of drug-resistant ...... th a combination drug regimen.
@en
Transmission of drug-resistant ...... th a combination drug regimen.
@nl
type
label
Transmission of drug-resistant ...... th a combination drug regimen.
@en
Transmission of drug-resistant ...... th a combination drug regimen.
@nl
prefLabel
Transmission of drug-resistant ...... th a combination drug regimen.
@en
Transmission of drug-resistant ...... th a combination drug regimen.
@nl
P2093
P2860
P356
P1476
Transmission of drug-resistant ...... th a combination drug regimen.
@en
P2093
Chi-Cheng Luo
Denise M Cardo
Elise M Beltrami
Nicolas de la Torre
P2860
P304
P356
10.1086/502065
P577
2002-06-01T00:00:00Z